Tag: FDA
-
Making Blood Donation More Inclusive: The ADVANCE Study
In December 2020, the American Red Cross, OneBlood and Vitalant, together representing over 50% of the blood supply in the United States, initiated the ADVANCE (Assessing Donor Variability And New Concepts in Eligibility) Study. ADVANCE was a pilot study funded by a contract from the US Food and Drug Administration (FDA) that could potentially lead…